LianBio financial data

Symbol
LIANY on OTC
Location
103 Carnegie Center Drive, Suite 309, Princeton, NJ
State of incorporation
Cayman Islands
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2023 - Nov 13, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.18K % -32%
Debt-to-equity 11.3 % -20.9%
Return On Equity -33.2 % -1.56%
Return On Assets -30.2 % -4.35%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 108M shares -0.27%
Common Stock, Shares, Outstanding 107M shares -1.09%
Entity Public Float 97.3M USD
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 107M shares -1.1%
Weighted Average Number of Shares Outstanding, Diluted 107M shares -1.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 39.9M USD -29.8%
General and Administrative Expense 66.7M USD +8.75%
Operating Income (Loss) -107M USD +9.81%
Income Tax Expense (Benefit) 874K USD +9667%
Net Income (Loss) Attributable to Parent -88M USD +22.3%
Earnings Per Share, Basic -0.81 USD/shares -141%
Earnings Per Share, Diluted -0.81 USD/shares -141%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 103M USD +31.2%
Marketable Securities, Current 149M USD -36.1%
Cash, Cash Equivalents, and Short-term Investments 252M USD -19.1%
Assets, Current 258M USD -20.5%
Property, Plant and Equipment, Net 2.36M USD -24.6%
Operating Lease, Right-of-Use Asset 2.64M USD -39.4%
Other Assets, Noncurrent 20K USD -45.9%
Assets 263M USD -25.3%
Accounts Payable, Current 6.23M USD +209%
Accrued Liabilities, Current 15.9M USD -11.1%
Liabilities, Current 25.6M USD +16.3%
Operating Lease, Liability, Noncurrent 950K USD -68.5%
Other Liabilities, Noncurrent 213K USD +6.5%
Liabilities 26.8M USD -40.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.22M USD +16.2%
Retained Earnings (Accumulated Deficit) -540M USD -19.5%
Stockholders' Equity Attributable to Parent 202M USD -25.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 236M USD -23%
Liabilities and Equity 263M USD -25.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17.6M USD -34.6%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 40.5M USD
Common Stock, Shares Authorized 2.92B shares 0%
Common Stock, Shares, Issued 107M shares -1.09%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 23.1M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 104M USD +4.64%
Deferred Tax Assets, Valuation Allowance 13.5M USD +41%
Deferred Tax Assets, Gross 14.4M USD +36.3%
Operating Lease, Liability 4.34M USD -10.2%
Depreciation 1.26M USD +35.4%
Payments to Acquire Property, Plant, and Equipment 19K USD -94.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -87.4M USD +25.4%
Lessee, Operating Lease, Liability, to be Paid 4.78M USD -14.6%
Property, Plant and Equipment, Gross 4.79M USD +10.1%
Operating Lease, Liability, Current 1.89M USD +8.17%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.09M USD +12.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.13M USD +40.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 441K USD -42.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 561K USD -69.3%
Deferred Tax Assets, Operating Loss Carryforwards 8.37M USD +31.7%
Deferred Tax Assets, Net of Valuation Allowance 860K USD -10.7%